Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pasteurella multocida septic arthritis

J W Mellors, R T Schoen

    Connecticut Medicine
    |April 1, 1984
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Measurement of plasma HIV-1 RNA below the limit of quantification (<20 copies/mL) of commercial assays with the integrase HIV RNA single-copy assay.

    Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology·2018
    Same author

    HIV latency. Specific HIV integration sites are linked to clonal expansion and persistence of infected cells.

    Science (New York, N.Y.)·2014
    Same author

    Nucleic Acid, Antibody, and Virus Culture Methods to Detect Xenotropic MLV-Related Virus in Human Blood Samples.

    Advances in virology·2012
    Same author

    Prevalence of XMRV nucleic acid and antibody in HIV-1-Infected men and in men at risk for HIV-1 Infection.

    Advances in virology·2012
    Same author

    Short-course raltegravir intensification does not reduce persistent low-level viremia in patients with HIV-1 suppression during receipt of combination antiretroviral therapy.

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2010
    Same author

    Treatment intensification does not reduce residual HIV-1 viremia in patients on highly active antiretroviral therapy.

    Proceedings of the National Academy of Sciences of the United States of America·2009